MFN2 and breast carcinoma: To investigate the effect of MFN2 in breast and lung cancer cells, MFN2 was knocked out by transfection of a Crispr/Cas9 KO plasmid in MCF-7, a breast cancer cell line, and A549, a lung cancer cell line.